
Eastman Chemical Co. Stock Plummets to New 52-Week Low at $56.75
2025-11-05 16:30:04Eastman Chemical Co. has reached a new 52-week low, with a significant stock price decline over the past year. The company, with a market capitalization of approximately USD 13.93 billion, faces challenges in long-term growth, as indicated by modest increases in net sales and operating profit.
Read More
Eastman Chemical Co. Experiences Revision in Its Stock Evaluation Amid Market Dynamics
2025-10-27 15:40:42Eastman Chemical Co. has adjusted its valuation, reflecting changes in financial metrics such as a P/E ratio of 16 and a price-to-book value of 2.72. The company demonstrates strong operational efficiency with an EV to EBIT ratio of 14.94 and a robust dividend yield, highlighting its financial health within the Chemicals & Petrochemicals industry.
Read MoreIs Eastman Chemical Co. overvalued or undervalued?
2025-10-26 11:08:00As of 24 October 2025, the valuation grade for Eastman Chemical Co. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears to be overvalued based on its P/E ratio of 16, which is notably higher than its peer, Innospec, Inc., with a P/E of 14.56, and significantly lower than Element Solutions, Inc., which has a P/E of 24.64. Additionally, Eastman’s EV to EBITDA ratio stands at 10.92, while its PEG ratio is quite high at 3.28, suggesting that the stock may not be a good value relative to its growth prospects. In comparison to its peers, Eastman Chemical Co. shows a less favorable valuation profile, particularly when juxtaposed with the fair valuations of Element Solutions and Avient Corp. Furthermore, the company's recent stock performance has lagged significantly behind the S&P 500, with a year-to-date return of -31.34% compared to the S&P 500's 15.47%. Th...
Read MoreIs Eastman Chemical Co. overvalued or undervalued?
2025-10-21 12:03:35As of 17 October 2025, the valuation grade for Eastman Chemical Co. has moved from expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, given its P/E ratio of 16, which is significantly lower than the industry average, and an EV to EBITDA ratio of 10.92, suggesting a more appealing valuation compared to peers. Additionally, the PEG ratio stands at 3.28, which, while high, reflects growth expectations that may not be fully priced in. In comparison to peers, Eastman Chemical Co. has a more attractive P/E ratio than Element Solutions, Inc. at 24.64 and Avient Corp. at 79.68, which indicates that it is trading at a discount relative to these companies. Furthermore, the company's ROE of 16.69% and ROCE of 13.16% demonstrate solid profitability metrics. Despite recent underperformance, with a 1Y return of -44.01% compared to the S&P 500's 14.08%, the c...
Read More
Eastman Chemical Co. Experiences Valuation Adjustment Amidst Competitive Market Landscape
2025-10-20 15:56:04Eastman Chemical Co. has adjusted its valuation, now featuring a P/E ratio of 16, which is lower than some competitors. The company demonstrates strong profitability with a 16.69% ROE and a 13.16% ROCE. Despite a challenging year, it has recently outperformed the S&P 500.
Read MoreIs Eastman Chemical Co. overvalued or undervalued?
2025-10-20 12:21:06As of 17 October 2025, the valuation grade for Eastman Chemical Co. has moved from expensive to attractive, indicating a more favorable assessment of its value. The company appears undervalued, particularly when considering its P/E ratio of 16, which is significantly lower than the peer average of 15.68, and its EV to EBITDA ratio of 10.92, also below the peer average of 10.37. Additionally, Eastman boasts a robust ROE of 16.69%, suggesting effective management of equity. In comparison to its peers, Element Solutions, Inc. has a P/E ratio of 24.64, while Innospec, Inc. shows an attractive valuation with a P/E of 14.56. Despite recent stock performance showing a decline, with a YTD return of -32.90% compared to the S&P 500's 13.30%, the current valuation metrics suggest that Eastman Chemical Co. may present a compelling investment opportunity....
Read MoreIs Eastman Chemical Co. overvalued or undervalued?
2025-10-19 11:58:44As of 17 October 2025, the valuation grade for Eastman Chemical Co. has moved from expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, particularly when considering its P/E ratio of 16, which is significantly lower than the average of its peers, such as Element Solutions, Inc. at 24.64 and Avient Corp. at 79.68. Additionally, Eastman has an EV to EBITDA ratio of 10.92, which is more appealing compared to the industry average, suggesting better value relative to earnings before interest, taxes, depreciation, and amortization. In terms of performance, Eastman Chemical Co. has experienced a challenging year, with a 1-year return of -44.01%, compared to the S&P 500's return of 14.08%, highlighting the stock's underperformance in the market. However, with a PEG ratio of 3.28 and a dividend yield of 243.20%, the company offers potential for future gro...
Read More
Eastman Chemical Co. Experiences Valuation Adjustment Amidst Competitive Market Dynamics
2025-10-06 15:50:07Eastman Chemical Co. has adjusted its valuation, reflecting shifts in financial metrics within the Chemicals & Petrochemicals industry. The company reports a P/E ratio of 16, a price-to-book value of 2.72, and a robust dividend yield. Its performance metrics show challenges in stock returns compared to the S&P 500.
Read MoreIs Eastman Chemical Co. overvalued or undervalued?
2025-10-05 11:13:53As of 3 October 2025, the valuation grade for Eastman Chemical Co. has moved from attractive to very expensive, indicating a significant shift in its valuation outlook. The company is currently considered overvalued, with a P/E ratio of 16, a Price to Book Value of 2.72, and an EV to EBITDA of 10.92. In comparison, peers such as Element Solutions, Inc. have a much higher P/E of 24.64, while Ingevity Corp. stands at a lower P/E of 11.75, highlighting the relative overvaluation of Eastman. The company's recent performance shows a stark contrast to the S&P 500, with a year-to-date return of -29.88% compared to the index's 14.18%, and a one-year return of -40.67% against 17.82% for the S&P 500. This underperformance reinforces the notion that Eastman Chemical Co. is currently overvalued in the market....
Read More





